Th2 cells have been reported to promote tumor progression by releasing inflammatory factors such as IL-4/IL-13, and by promoting M2 macrophage polarization and activation of myeloid-derived suppressor cells (MDSCs) [39]. The gene discussed is IL13; the disease is neoplasm.